Philip Grossen is a scientist specializing in drug delivery and cell and gene therapy technical development. They held positions as Principal Scientist at Roche and Senior Scientist for Gene Therapies, focusing on drug product development for CAR-T therapies and technical oversight of manufacturing processes. Their educational background includes a PhD in Pharmaceutical Sciences from Universität Basel, where they conducted research on nanoparticulate drug delivery systems and anticancer gene therapies. Philip's experience spans various prestigious institutions, showcasing a commitment to advancing therapeutic strategies in oncology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices